Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Ma, Shuangtao ^a   Yang, Dachun ^a   Li, De ^a   Tang, Bing ^a   Yang, Yongjian ^a  

^a General Hospital of PLA Chengdu Military Area Command   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; CD36 ANTIGEN; FATTY ACID; OLEIC ACID; SULFO N SUCCINIMIDYL OLEATE; UNCLASSIFIED DRUG; APOLIPOPROTEIN E;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; FOAM CELL; IN VIVO STUDY; MUSCLE CELL; NONHUMAN; RAT; SMOOTH MUSCLE; ANIMAL; AORTA; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; GENETICS; MALE; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; WISTAR RAT;

MUS; RATTUS;

ANIMALS; ANTIGENS, CD36; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; CELLS, CULTURED; FOAM CELLS; MALE; MICE; MYOCYTES, SMOOTH MUSCLE; OLEIC ACID; PLAQUE, ATHEROSCLEROTIC; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79953842977     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-53     Document Type: Article

References (25)

1. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. D Siegel-Axel K Daub P Seizer S Lindemann M Gawaz, Cardiovasc Res 2008 78 8 17 10.1093/cvr/cvn015 18218686 (Pubitemid 351430965)
2. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. AC Doran N Meller CA McNamara, Arterioscler Thromb Vasc Biol 2008 28 812 819 10.1161/ATVBAHA.107.159327 18276911 (Pubitemid 351544093)
3. Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. M Klouche S Rose-John W Schmiedt S Bhakdi, Circulation 2000 101 1799 1805 10769280 (Pubitemid 30213101)
4. Lipid accumulation in smooth muscle cells under LDL loading is independent of LDL receptor pathway and enhanced by hypoxic conditions. Y Wada A Sugiyama T Yamamoto M Naito N Noguchi S Yokoyama M Tsujita Y Kawabe M Kobayashi A Izumi,, et al. Arterioscler Thromb Vasc Biol 2002 22 1712 1719 10.1161/01.ATV.0000033834.57737.9B 12377754
5. Development of the smooth muscle foam cell: uptake of macrophage lipid inclusions. G Wolfbauer JM Glick LK Minor GH Rothblat, Proc Natl Acad Sci USA 1986 83 7760 7764 10.1073/pnas.83.20.7760 3020555 (Pubitemid 17183924)
6. Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells. Evidence for reduced posttranscriptional processing of cyclooxygenase I and reduced cyclooxygenase II gene expression. KB Pomerantz B Summers DP Hajjar, Biochemistry 1993 32 13624 13635 10.1021/bi00212a030 8257696 (Pubitemid 24020239)
7. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. S Pilz H Scharnagl B Tiran U Seelhorst B Wellnitz BO Boehm JR Schaefer W Marz, J Clin Endocrinol Metab 2006 91 2542 2547 10.1210/jc.2006-0195 16595593 (Pubitemid 44024615)
8. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. M Pirro P Mauriege A Tchernof B Cantin GR Dagenais JP Despres B Lamarche, Atherosclerosis 2002 160 377 384 10.1016/S0021-9150(01)00588-3 11849661 (Pubitemid 34159331)
9. Free fatty acids and atherosclerosis - guilty or innocent? SR Smith PW Wilson, J Clin Endocrinol Metab 2006 91 2506 2508 10.1210/jc.2006-1018 16825577 (Pubitemid 44024609)
10. Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. J Hua X Ma T Webb JJ Potter M Oelke Z Li, J Lipid Res 2010 51 1696 1703 10.1194/jlr.M003004 20185414
11. Fatty acid composition of skeletal muscle reflects dietary fat composition in humans. A Andersson C Nalsen S Tengblad B Vessby, Am J Clin Nutr 2002 76 1222 1229 12450886 (Pubitemid 35416555)
12. CD36 and macrophages in atherosclerosis. S Collot-Teixeira J Martin C McDermott-Roe R Poston JL McGregor, Cardiovasc Res 2007 75 468 477 10.1016/j.cardiores.2007.03.010 17442283 (Pubitemid 47080960)
13. Endothelin-1 decreases CD36 protein expression in vascular smooth muscle cells. CF Kwok CC Juan LT Ho, Am J Physiol Endocrinol Metab 2007 292 648 652 10.1152/ajpendo.00084.2006 16985264
14. Fatty acid (FFA) transport in cardiomyocytes revealed by imaging unbound FFA is mediated by an FFA pump modulated by the CD36 protein. AN Carley AM Kleinfeld, J Biol Chem 2011 286 4589 4597 10.1074/jbc.M110.182162 21147770
15. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation. JX Rong J Kusunoki P Oelkers SL Sturley EA Fisher, Arterioscler Thromb Vasc Biol 2005 25 122 127 15499046 (Pubitemid 40054264)
16. PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs. HJ Lim S Lee KS Lee JH Park Y Jang EJ Lee HY Park, Prostaglandins Other Lipid Mediat 2006 80 165 174 10.1016/j.prostaglandins.2006. 06.006 16939881 (Pubitemid 44287587)
17. Overloading human aortic smooth muscle cells with low density lipoprotein-cholesteryl esters reproduces features of atherosclerosis in vitro. JL Goldstein RG Anderson LM Buja SK Basu MS Brown, J Clin Invest 1977 59 1196 1202 10.1172/JCI108744 193874 (Pubitemid 8131075)
18. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. D Tripathy P Mohanty S Dhindsa T Syed H Ghanim A Aljada P Dandona, Diabetes 2003 52 2882 2887 10.2337/diabetes.52.12.2882 14633847 (Pubitemid 37466856)
19. Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. JG Schneider Z Yang MV Chakravarthy IJ Lodhi X Wei J Turk CF Semenkovich, J Biol Chem 2010 285 23398 23409 10.1074/jbc.M110.100321 20479009
20. Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir. W Guo S Wong J Pudney R Jasuja N Hua L Jiang A Miller PW Hruz JA Hamilton S Bhasin, Arterioscler Thromb Vasc Biol 2009 29 2028 2032 10.1161/ATVBAHA.109.191304 19762785
21. Overexpression of angiotensin II type 2 receptor suppresses neointimal hyperplasia in a rat carotid arterial balloon injury model. B Tang ST Ma YJ Yang DC Yang JS Chen XH Su Y Tan MQ Sun D Li, mol Med Rep 2011 4 249 254
22. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. JS Isenberg Y Jia J Fukuyama CH Switzer DA Wink DD Roberts, J Biol Chem 2007 282 15404 15415 10.1074/jbc.M701638200 17416590 (Pubitemid 47093297)
23. Angiotensin II receptor blockade improves matrix metalloproteinases/ tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium. D Yang S Ma D Li B Tang Y Yang, Biochem Biophys Res Commun 2009 388 606 611 10.1016/j.bbrc.2009.08.073 19695229
24. Increased expression of calpain and elevated activity of calcineurin in the myocardium of patients with congestive heart failure. D Yang S Ma Y Tan D Li B Tang X Zhang M Sun Y Yang, Int J Mol Med 2010 26 159 164 20514436
25. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. M Furuhashi G Tuncman CZ Gorgun L Makowski G Atsumi E Vaillancourt K Kono VR Babaev S Fazio MF Linton,, et al. Nature 2007 447 959 965 10.1038/nature05844 17554340 (Pubitemid 46975747)